维普中文期刊产品整合服务
1085篇 您的检索式:作者名="Roderic"
    题名 作者 年代 出处 被引量
1Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with de novo inflammatory bowel disease显示文摘AIM To evaluate risk factors for primary sclerosing cholangitis(PSC) recurrence(rPSC) after orthotopic liver transplantation(OLT) in patients with well-preserved colons. METHODS We retrospectively evaluated the medical records of all patients transplanted for PSC in our center between July 1994 and May 2015 and selected 47 with followup of at least 60 mo for further analysis based on strict inclusion and exclusion criteria. rPSC was confirmed by magnetic resonance or endoscopic retrograde cholangiopancreatography and liver biopsy. All patients were evaluated by protocolary pre-OLT colonoscopy with randomized mucosal biopsies. Colonoscopy was repeated annually after OLT. Both organ donors and recipients were human leukocyte antigen(HLA) typed by serological and/or DNA methods. All input data were thoroughly analyzed employing relevant statistical methods.RESULTS Altogether, 31 men and 16 women with a median(range) age of 36(15-68) years at the time of OLT and a median follow-up of 122(60-249) mo were included. rPSC was confirmed in 21/47(44.7%) of patients, a median 63(12-180) mo after transplantation. De novo colitis [rPSC in 11/12, P ≤ 0.05, hazard ratio(HR): 4.02, 95% confidence interval(CI): 1.58-10.98] and history of acute cellular rejection(rPSC in 14/25, P ≤ 0.05; HR: 2.66, 95%CI: 1.03-7.86) showed strong positive associations with rPSC. According to the univariate analysis, overlapping features of autoimmune hepatitis(r PSC in 5/5, P ≤ 0.05) and HLA-DRB1*07 in the donor(r PSC in 10/15, P ≤ 0.05) represent other potential risk factors for rPSC, while the HLA-DRB1*04(rPSC in 0/6, P ≤ 0.05), HLA-DQB1*03(rPSC in 1/11, P ≤ 0.05), and HLA-DQB1*07(rPSC in 0/7, P ≤ 0.05) recipient alleles may have protective roles.CONCLUSION De novo colitis and acute cellular rejection are clinical conditions significantly predisposed towards recurrence of PSC after liver transplantation.Lukas Bajer Antonij Slavcev Peter Macinga Eva Sticova Jan Brezina Matej Roder Radim Janousek Pavel Trunecka Julius Spicak Pavel Drastich 2018World Journal of Gastroenterology2018,24,43:4
2Brain metastasis in advanced colorectal cancer: results from the South Australian metastatic colorectal cancer (SAmCRC) registry显示文摘Objective:Brain metastasis is considered rare in metastatic colorectal cancer(mCRC);thus,surveillance imaging does not routinely include the brain.The reported incidence of brain metastases ranges from 0.6% to 3.2%.Methods:The South Australian mCRC Registry(SAmCRC)was analyzed to assess the number of patients presenting with brain metastasis during their lifetime.Due to small numbers,a descriptive analysis is presented.Results:Only 59 patients of 4,100 on the registry at the time of analysis had developed brain metastasis(1.4%).The clinical characteristics of those with brain metastasis were as follows:the median age was 65.3 years and 51% were female.Where the V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog(KRAS)mutation status of the tumor was known,the majority harbored a KRAS mutation(55%);31(53%)underwent craniotomy and 55(93%)underwent whole-brain radiotherapy.The median survival time from diagnosis of brain metastasis was 4.2 months(95% confidence interval 2.9–5.5).Patients who underwent craniotomy and radiotherapy had superior survival compared to those who underwent whole-brain radiotherapy(8.5 months vs.2.2 months,respectively).Data from the SAmCRC(a population-based registry)confirm that brain metastases are rare and the median time to development is approximately 2 years.Conclusions:Brain metastasis is a rare outcome in advanced CRC.Patients within the registry tended to be female,young in age,and harbored with higher rates of KRAS mutations.Whether routine surveillance brain scanning should be considered remains controversial given the relative rarity of developing brain metastases in mCRC and ultimately,most patients with central nervous system involvement die from their extracranial disease.Gonzalo Tapia Rico Timothy J. Price Christos Karapetis Cynthia Piantadosi Rob Padbury Amitesh Roy Guy Maddern James Moore Scott Carruthers David Roder Amanda R. Townsend 2017Cancer Biology & Medicine2017,14,4:3
3A microsatellite map of wheat显示文摘Roder M S KorzunV Wendehake K 1998Genetics1998,149,:2
4Epidemiology of neuroendocrine cancers in an Australian population显示文摘Colin Luke Timothy Price Amanda Townsend Christos Karapetis Dusan Kotasek Nimit Singhal Elizabeth Tracey David Roder 2010Cancer Causes & Control2010,,6:2
5A microsatellite map of wheat显示文摘Roder M S Korzun V Wendehake K 1998Genetics1998,149,4:2
6The epidemiology of gastric cancer显示文摘David M. Roder 2002Gastric Cancer2002,,1:2
7Synthesis of oligonucleotide funetionalized magnetic nanoparticles and study on their in vitro cell uptake显示文摘Wagner K Kautz A Roder M 2004Appl Organometal Chem2004,18,:1
8A microsatellite map of wheat显示文摘Roder MS Korzun V Wendehake K 1998Genetics1998,149,:1
9Factors predictive of corneal graft survival:report fromo the Australian corneal graft registry显示文摘WILLIAMS KA RODER D ESTERMAN A 1992Ophthalmology1992,99,:1
10Prognostic Factors in Gastric Carcinoma:Result s of the German Gastric Carcinoma Study 1992显示文摘RODER J D BOTTCHER K SIEWERT J R 1993Cancer1993,72,8:1
11Acoustic noise source modeling based on microphone array measurement显示文摘Brühl S Roder A 2000Journal of Sound and Vibration2000,231,3:1
12A microsatellite map of wheat显示文摘Roder M S Korzun V Wendehake K 1998Genetic1998,149,:1
13Learning and memory in S100-βtransgenic mice:an analysis of impaired and preserved function显示文摘Winocur G Roder J Lobaugh N 2001Neurobiol Learn Mem2001,75,2:1
14Stented versus non- stented pancreaticojejunostomy after pancreatoduodeneetomy: a prospective study显示文摘Roder JD Stein HJ B? ttcher KA 1999Ann Surg1999,229,1:1
15Frequencies and sequence charateristics of di-, tri-, and tetranucleo-cide microsatellites in wheat显示文摘Ma Z Q Roder M S Sorrells M E 1996Genome1996,39,:1
16Vaccination withmage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma显示文摘 Haendle I Roder C 1999J Exp Med1999,190,11:1
17MS Detection of genetic diversity in closely elated breed wheat using microsatellite markers显示文摘 GANAL M W RODER M S 1995Theor Appl Genet1995,91,:1
18Reasons for Improved Survival From Ovarian Cancer in New South Wales, Australia, Between 1980 and 2003 Implications for Cancer Control 显示文摘Traeey EA Roder DM 2009Int J Gynecol Cancer2009,19,4:1
19Construction and analysis of a microsatellite-based database of European wheat varieties显示文摘Roder M S Wendehake K Korzun V 2002Theoretical and Applied Genetics2002,,106:1
20Disseminated intravascular coagulation: clinical and laboratory aspects显示文摘Carey MJ Roders GM 1998Am J Hematol1998,59,1:1
返回顶部 每页显示:
共55页 首页 上一页 第1页 下一页 末页 /55 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费